525 related articles for article (PubMed ID: 10640953)
1. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
2. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
[TBL] [Abstract][Full Text] [Related]
3. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
Zhang AM; Chi XH; Bo ZQ; Huang XF; Zhang J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31439759
[TBL] [Abstract][Full Text] [Related]
4. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues.
Bahar R; Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Dec; 26(6):443-6. PubMed ID: 9418147
[TBL] [Abstract][Full Text] [Related]
6. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
[TBL] [Abstract][Full Text] [Related]
7. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma.
Kamikawa Y; Kanmura Y; Hamada T; Yamada N; Macha MA; Batra SK; Higashi M; Yonezawa S; Sugihara K
Int J Clin Oncol; 2015 Apr; 20(2):298-307. PubMed ID: 24909613
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
[TBL] [Abstract][Full Text] [Related]
9. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
10. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
11. Effect of smoking on MUC1 expression in oral epithelial dysplasia, oral cancer, and irradiated oral epithelium.
Kashyap B; Mikkonen JJW; Bhardwaj T; Dekker H; Schulten EAJM; Bloemena E; Kullaa AM
Arch Oral Biol; 2022 Oct; 142():105525. PubMed ID: 36027639
[TBL] [Abstract][Full Text] [Related]
12. Expression of MUC1 mucin in potentially malignant disorders, oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study.
Kumar MH; Sanjai K; Kumarswamy J; Keshavaiah R; Papaiah L; Divya S
J Oral Maxillofac Pathol; 2016; 20(2):214-8. PubMed ID: 27601811
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
14. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
15. Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions.
Bryne M; Reibel J; Mandel U; Dabelsteen E
J Oral Pathol Med; 1991 Mar; 20(3):120-5. PubMed ID: 1709970
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.
Chaves FN; Bezerra TMM; Moraes DC; Costa SFDS; Silva PGB; Alves APNN; Costa FWG; Bernardes VF; Pereira KMA
Exp Mol Pathol; 2020 Feb; 112():104341. PubMed ID: 31730755
[TBL] [Abstract][Full Text] [Related]
17. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
18. Stromelysin-3 expression is an early event in human oral tumorigenesis.
Soni S; Mathur M; Shukla NK; Deo SV; Ralhan R
Int J Cancer; 2003 Nov; 107(2):309-16. PubMed ID: 12949813
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan.
Fong Y; Chou SJ; Hung KF; Wu HT; Kao SY
J Chin Med Assoc; 2008 Mar; 71(3):123-7. PubMed ID: 18364263
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
